Clinical Trial Update: Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing gemcitabine plus carboplatin versus carboplatin alone in advanced ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Paraplatin (Carboplatin)

Snippet

Sponsor: AGO Study Group | Conditions: Ovarian Cancer | Phase 3 | Status: COMPLETED